Eva Klein

16.7k total citations · 6 hit papers
310 papers, 13.0k citations indexed

About

Eva Klein is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Eva Klein has authored 310 papers receiving a total of 13.0k indexed citations (citations by other indexed papers that have themselves been cited), including 194 papers in Immunology, 125 papers in Oncology and 54 papers in Molecular Biology. Recurrent topics in Eva Klein's work include Immune Cell Function and Interaction (122 papers), Viral-associated cancers and disorders (73 papers) and T-cell and B-cell Immunology (54 papers). Eva Klein is often cited by papers focused on Immune Cell Function and Interaction (122 papers), Viral-associated cancers and disorders (73 papers) and T-cell and B-cell Immunology (54 papers). Eva Klein collaborates with scholars based in Sweden, United States and Hungary. Eva Klein's co-authors include George Klein, Hans Wigzell, Rolf Kiessling, George Klein, Hans Olof Sjögren, Hugh F. Pross, Mitsuo Takasugi, Farkas Vánky, Peter Clifford and Noémi Nagy and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Eva Klein

304 papers receiving 11.8k citations

Hit Papers

„Natural” killer cells in the mouse. I. Cytotoxic cells w... 1960 2026 1982 2004 1975 1975 1968 1960 1985 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. „Natural” killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype
    1975 1.4k citations Rolf Kiessling, Eva Klein et al. European Journal of Immunology profile →
  2. „Natural” killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell
    1975 852 citations Rolf Kiessling, Eva Klein et al. European Journal of Immunology profile →
  3. Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.
    1968 772 citations Eva Klein et al. profile →
  4. Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.
    1960 565 citations George Klein, Eva Klein et al. profile →
  5. Evolution of tumours and the impact of molecular oncology
    1985 539 citations George Klein, Eva Klein profile →
  6. A MICROASSAY FOR CELL-MEDIATED IMMUNITY
    1970 389 citations Eva Klein et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Klein Sweden 53 7.6k 4.6k 3.1k 1.6k 1.6k 310 13.0k
Ivan D. Horak United States 62 5.7k 0.7× 3.9k 0.9× 4.8k 1.5× 1.8k 1.2× 1.0k 0.7× 205 14.0k
Jeffrey A. Ledbetter United States 52 10.4k 1.4× 2.6k 0.6× 3.8k 1.2× 2.7k 1.7× 801 0.5× 118 14.8k
Chikao Morimoto United States 74 8.4k 1.1× 5.6k 1.2× 5.1k 1.6× 2.2k 1.4× 952 0.6× 339 18.5k
Ion Gresser France 62 8.7k 1.1× 4.0k 0.9× 2.9k 0.9× 1.3k 0.9× 515 0.3× 245 14.3k
Hiroshi Shiku Japan 64 6.6k 0.9× 4.4k 1.0× 6.7k 2.1× 1.4k 0.9× 1.5k 1.0× 535 16.3k
Francis W. Ruscetti United States 55 11.0k 1.4× 2.3k 0.5× 4.6k 1.5× 863 0.6× 585 0.4× 144 17.0k
Kazuo Sugamura Japan 78 12.2k 1.6× 4.0k 0.9× 4.9k 1.6× 830 0.5× 584 0.4× 304 20.8k
B Perussia United States 63 10.5k 1.4× 2.5k 0.6× 3.0k 1.0× 1.7k 1.1× 478 0.3× 132 14.3k
J A Ledbetter United States 52 9.4k 1.2× 2.0k 0.4× 3.2k 1.0× 2.1k 1.4× 507 0.3× 99 12.7k
Leonard Chess United States 60 8.4k 1.1× 1.5k 0.3× 2.3k 0.7× 2.5k 1.6× 781 0.5× 148 12.5k

Countries citing papers authored by Eva Klein

Since Specialization
Citations

This map shows the geographic impact of Eva Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Klein more than expected).

Fields of papers citing papers by Eva Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Klein. The network helps show where Eva Klein may publish in the future.

Co-authorship network of co-authors of Eva Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Klein. A scholar is included among the top collaborators of Eva Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Klein. Eva Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heuts, Frank, Martı́n E. Rottenberg, Dániel Salamon, et al.. (2014). T Cells Modulate Epstein-Barr Virus Latency Phenotypes during Infection of Humanized Mice. Journal of Virology. 88(6). 3235–3245. 29 indexed citations
2.
Klein, Eva, Anquan Liu, & Hans‐Erik Claesson. (2008). Activation of innate immunity by the leukotriene B 4 inhibits EBV induced B-cell transformation in cord-blood derived mononuclear cultures. Immunology Letters. 116(2). 174–177. 11 indexed citations
3.
Bandobashi, Kentaro, Akihiko Maeda, Norihiro Teramoto, et al.. (2001). Intranuclear Localization of the Transcription Coadaptor CBP/p300 and the Transcription Factor RBP-Jk in Relation to EBNA-2 and -5 in B Lymphocytes. Virology. 288(2). 275–282. 14 indexed citations
4.
Klein, Eva. (1998). The complexity of the Epstein-Barr virus infection in humans. Pathology & Oncology Research. 4(1). 3–7. 21 indexed citations
5.
Avila‐Cariño, Javier, Jan Andersson, Håkan Mellstedt, & Eva Klein. (1996). B-CLL cells experimentally infected with EBV enter DNA synthesis, produce cytokines and stimulate T-lymphocytes. Immunology Letters. 54(1). 45–52. 8 indexed citations
6.
Lewin, Nongnit, et al.. (1995). Detection of two epstein‐barr‐virus (EBV)‐carrying leukemic cell clones in a patient with chronic lymphocytic leukemia (CLL). International Journal of Cancer. 61(2). 159–164. 9 indexed citations
7.
Yefenof, Eitan, et al.. (1994). Alternative complement pathway activation by CD4+ T cells of HIV infected individuals: a possible role in AIDS pathogenesis. International Immunology. 6(9). 1361–1366. 5 indexed citations
8.
Stuber, György, Gerhard Leder, Walter J. Storkus, et al.. (1994). Identification of wild‐type and mutant p53 peptides binding to HLA‐A2 assessed by a peptide loading‐deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay. European Journal of Immunology. 24(3). 765–768. 61 indexed citations
9.
Klein, Eva & Alberto Mantovani. (1993). Action of natural killer cells and macrophages in cancer. Current Opinion in Immunology. 5(5). 714–718. 37 indexed citations
10.
11.
Kuraya, Mikio, George Klein, Eva Klein, & Eitan Yefenof. (1992). Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum‐mediated lysis. European Journal of Immunology. 22(7). 1871–1876. 33 indexed citations
12.
Yefenof, Eitan, et al.. (1991). Potentiation of T cell immunity against radiation-leukemia-virus-induced lymphoma by polysaccharide K. Cancer Immunology Immunotherapy. 34(2). 133–137. 7 indexed citations
13.
Åman, Pierre, Martin Rowe, Chieko Kai, et al.. (1990). Effect of the ebna‐2 gene on the surface antigen phenotype of transfected ebv‐negative B‐lymphoma lines. International Journal of Cancer. 45(1). 77–82. 21 indexed citations
14.
Torsteinsdóttir, Sigurbjörg, et al.. (1988). Combined treatment with interferon (IFN)-γ and tumor necrosis factor (TNF)-α up-regulates the expression of HLA class I determinants in Burkitt lymphoma lines. Cellular Immunology. 117(2). 303–311. 15 indexed citations
15.
Kai, Chieko, Robert Szigeti, Pierre Åman, & Eva Klein. (1988). Activation of B lymphocytes with human serum-treated zymosan. Cellular Immunology. 116(2). 467–474. 3 indexed citations
16.
Klein, Eva. (1987). Baldomero Sanín Cano: crítico literario del período de modernización colombiano. 3. 41–55. 1 indexed citations
17.
18.
Kiessling, Rolf & Eva Klein. (1973). CYTOTOXIC POTENTIAL OF MOUSE SPLEEN CELLS ON H-2 ANTIBODY-TREATED TARGET CELLS. The Journal of Experimental Medicine. 137(2). 527–532. 22 indexed citations
19.
Skurzak, H, Eva Klein, Takato O. Yoshida, & E W Lamon. (1972). SYNERGISTIC OR ANTAGONISTIC EFFECT OF DIFFERENT ANTIBODY CONCENTRATIONS ON IN VITRO LYMPHOCYTE CYTOTOXICITY IN THE MOLONEY SARCOMA VIRUS SYSTEM. The Journal of Experimental Medicine. 135(4). 997–1002. 64 indexed citations
20.
ESKELAND, T., Eva Klein, Masaharu Inoue, & Bo Johansson. (1971). CHARACTERIZATION OF IMMUNOGLOBULIN STRUCTURES FROM THE SURFACE OF CHRONIC LYMPHOCYTIC LEUKEMIA CELLS. The Journal of Experimental Medicine. 134(1). 265–280. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivan D. Horak Breakdown of academic impact, for papers by Jeffrey A. Ledbetter Breakdown of academic impact, for papers by Chikao Morimoto Breakdown of academic impact, for papers by Ion Gresser Breakdown of academic impact, for papers by Hiroshi Shiku Breakdown of academic impact, for papers by Francis W. Ruscetti Breakdown of academic impact, for papers by Kazuo Sugamura Breakdown of academic impact, for papers by B Perussia Breakdown of academic impact, for papers by J A Ledbetter Breakdown of academic impact, for papers by Leonard Chess
Rankless by CCL
2026